Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: Attenuation with riluzole pretreatment

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1592-1600

  Springer, Joe E ^a   Azbill, Robert D ^a   Kennedy, Sarah E ^a   George, Jones ^a   Geddes, James W ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Calcium; Calpain I; CNS injury; Cytoskeleton; Glutamate; Microtubule associated protein 2; Riluzole; Spectrin

Indexed keywords

CALPAIN; CYTOSKELETON PROTEIN; GLUTAMIC ACID; MICROTUBULE ASSOCIATED PROTEIN 2; RILUZOLE; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CONTUSION; DENDRITIC CELL; DOSE RESPONSE; ENZYME ACTIVATION; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE CELL LESION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; RAT; SPINAL CORD INJURY;

ANIMALIA;

EID: 0030930824     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041592.x     Document Type: Article

References (60)

1. Anderson D. and Hall E. (1993) Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22, 987-992.
2. Arai A., Kessler M., Lee K., and Lynch G. (1990) Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Res. 532, 63-68.
3. Arlinghaus L., Mehdi S., and Lee K. S. (1991) Improved posthypoxic recovery with a membrane-permeable calpain inhibitor. Eur. J. Pharmacol. 209, 123-125.
4. Banik N., Hogan E., Powers J., and Whetstine L. (1982) Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem. Res. 7, 1465-1475.
5. Banik N., Happel R., Sostek M., Chiu F., and Hogan E. (1987) Ca2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation. Metab. Brain Dis. 2, 117-126.
6. Banik N., Matzelle D., Gantt-Wilford G., Osborne A., and Hogan E. (1997) Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752, 301-306.
7. Bartus R. T., Baker K. L., Heiser A. D., Sawyer S. D., Dean R. L., Elliott P. J., and Straub J. A. (1994) Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14, 537-544.
8. Basso D., Beattie M., and Breshnahan J. (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
9. Binder L. I., Frankfurter A., Kim H., Caceres A., Payne M. R., and Rebhun L. I. (1984) Heterogeneity of microtubule-associated protein 2 during rat brain development. Proc. Natl. Acad. Sci. USA 81, 5613-5617.
10. Binder L. I., Frankfurter A., and Rebhun L. I. (1986) Differential localization of MAP2 and tau in mammalian neurons in situ. Ann. NY Acad. Sci. 466, 145-166.
11. Caner H., Collins J. L., Harris S. M., Kassell N. F., and Lee K. S. (1993) Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607, 354-356.
12. Choi D. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
13. Cong J., Goll D., Peterson A., and Kapprell H. (1989) The role of autolysis in activity of the Ca2+-dependent proteinases (μ-calpain and m-calpain). J. Biol. Chem. 264, 10096-10103.
14. Constantini S. and Young W. (1994) The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80, 97-111.
15. Cotman C., Monaghan D., Ottersen O., and Storm-Mathisen J. (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10, 273-280.
16. Doble A. (1996) The pharmacology and mechanism of action of riluzole. Neurology 47, S233-S241.
17. Faden A., Lemke M., Simon R., and Noble L. (1988) N-Methyl-D-aspartate antagonist MK-801 improves outcome following traumatic spinal cord injury in rats: behavioral, anatomical, and neurochemical studies. J. Neurotrauma 5, 33-45.
18. Faden A. I., Demediuk P., Panter S. S., and Vink R. (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
19. Gentile N. and McIntosh T. (1993) Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury. Ann. Emerg. Med. 22, 1028-1034.
20. Gomez-Pinella F., Tram H., Cotman C., and Nieto-Sampedro M. (1989) Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp. Neurol. 104, 118-124.
21. Guttmann R., Elce J., Bell P., Isbell J., and Johnson G. (1997) Oxidation inhibits substrate proteolysis by calpain I but not autolysis. J. Biol. Chem. 272, 2005-2012.
22. Hayes R., Jenkin L., and Lyeth B. (1992) Neurotransmitter mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma 9, 173-187.
23. Hicks R. R., Smith D. H., and McIntosh T. K. (1995) Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res. 678, 151-160.
24. Iwasaki Y., Iizuka H., Yamamoto T., Konno H., and Kadoya S. (1985) Alleviation of axonal damage in acute spinal cord injury by a protease inhibitor: automated morphometric analysis of drug effects. Brain Res. 347, 124-126.
25. Iwasaki Y., Yamamoto H., Iizuka H., Yamamoto T., and Konno H. (1987) Suppression of neurofilament degradation by protease inhibitors in experimental spinal cord injury. Brain Res. 406, 99-104.
26. Johnson G., Jope R., and Binder L. (1989) Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163, 1505-1511.
27. Johnson G. V. W., Litersky J. M., and Jope R. S. (1991) Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56, 1630-1638.
28. Kampfl A., Whitson J. S., Zhao X., Posmantur R., Clifton G. L., and Hayes R. L. (1995) Calpain inhibitors reduce depolarization induced loss of tau protein in primary septohippocampal cultures. Neurosci. Lett. 194, 149-152.
29. Kampfl A., Posmantur R., Nixon. R., Grynspan F., Zhao X., Liu S., Newcomb J., Clifton G., and Hayes R. (1996a) μ-Calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67, 1575-1583.
30. Kampfl A., Zhao X., Whitson J. S., Posmantur R., Dixon C. E., Yang K., Clifton G. L., and Hayes R. L. (1996b) Calpain inhibitors protect against depolarization-induced neurofilament protein loss of septo-hippocampal neurons in culture. Eur. J. Neurosci. 8, 344-352.
31. Lee K. S., Frank S., Vanderklish P., Arai A., and Lynch G. (1991) Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA 88, 7233-7237.
32. Lynch D. R. and Dawson T. M. (1994) Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7, 510-516.
33. Matesic D. F. and Lin R. C. S. (1994) Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J. Neurochem. 63, 1012-1020.
34. Mattson M., Barger S., Begley J., and Mark R. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216.
35. Moriya T., Hassan A. Z., Young W., and Chesler M. (1994) Dynamics of extracellular calcium activity following contusion of the rat spinal cord. J. Neurotrauma 11, 255-263.
36. Panter S. S. and Faden A. I. (1992) Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci. Lett. 136, 165-168.
37. Panter S. S., Yum S. W., and Faden A. I. (1990) Alteration in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol. 27, 96-99.
38. Perlmutter L. S., Siman R., Gall C., Seubert P., Baudry M., and Lynch G. (1988) The ultrastructural localization of calcium-activated protease "calpain" in rat brain. Synapse 2, 79-88.
39. Posmantur R., Kampfl A., and Hayes R. (1997) A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875-888.
40. Posmantur R. M., Kampfl A., Liu S. J., Heck K., Taft W. C., Clifton G. L., and Hayes R. L. (1996) Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J. Neuropathol. Exp. Neurol. 55, 68-80.
41. Pratt J., Rataud J., Bardot F., Roux M., Blanchard J. C., Laduron P. M., and Stutzmann J. M. (1992) Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci. Lett. 140, 225-230.
42. Rami A. and Krieglstein J. (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609, 67-70.
43. Roberts-Lewis J. M. and Siman R. (1993) Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann. NY Acad. Sci. 679, 78-86.
44. Roberts-Lewis J. M., Savage M. J., Marcy V. R., Pinsker L. R., and Siman R. (1994) Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14, 3934-3944.
45. Saido T., Sorimachi H., and Suzuki K. (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814-822.
46. Samis J., Zboril G., and Elce J. (1987) Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies. Biochem. J. 246, 481-488.
47. Schlaepfer W. and Zimmerman U. (1985) Calcium-activated proteolysis in intermediate filaments. Ann. NY Acad. Sci. 455, 552-562.
48. Siman R. and Noszek J. (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1, 279-287.
49. Siman R., Gall C., Perlmutter L. S., Christian C., Baudry M., and Lynch G. (1985) Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res. 347, 399-403.
50. Siman R., Noszek J., and Kegerise C. (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9, 1579-1590.
51. Stutzmann J. M., Pratt J., Boraud T., and Gross C. (1996) The effect of riluzole on post-traumatic spinal cord injury in the rat. Neuroreport 7, 387-392.
52. Suzuki K., Imajoh S., Emori Y., Kawasaki H., Minami Y., and Ohno S. (1987) Calcium-activated neutral protease and its endogenous inhibitor: activation at the cell membrane and biological function. FEBS Lett. 220, 271-277.
53. Taft W. C., Yang K., Dixon C. E., and Hayes R. L. (1992) Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury. J. Neurotrauma 9, 281-290.
54. Tator C. and Fehlings M. (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
55. Wahl F., Allix M., Plotkine M., and Boulu R. G. (1993) Effect of riluzole on focal cerebral ischemia in rats. Eur. J. Pharmacol. 230, 209-214.
56. Wrathall J. R., Choiniere D., and Teng Y. D. (1994) Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14, 6598-6607.
57. Young W. (1992) Role of calcium in central nervous system injuries. J. Neurotrauma 9 (Suppl. 1), S9-S25.
58. Young W. (1993) Secondary injury mechanisms in acute spinal cord injury. J. Emerg. Med. 11 (Suppl. 1), 13-22.
59. Zimmerman U. and Schlaepfer W. (1984) Calcium-activated neutral protease (CANP) in brain and other tissues. Prog. Neurobiol. 23, 63-78.
60. Zimmerman U. and Schlaepfer W. (1991) Two stage autolysis of the catalytic subunit initiates activation of μ-calpain. Biochim. Biophys. Acta 1078, 192-198.